International Journal of Cardiology

Article	Citations
Suspected myocardial injury in patients with COVID-19: Evidence from front-line clinical observation in Wuhan, China	312
Diagnosis of arrhythmogenic cardiomyopathy: The Padua criteria	290
The cardiovascular burden of coronavirus disease 2019 (COVID-19) with a focus on congenital heart disease	189
Right ventricular dysfunction in critically ill COVID-19 ARDS	80
Cardiopulmonary exercise testing in COVID-19 patients at 3 months follow-up	78
Unusual arterial thrombotic events in Covid-19 patients	64
An anti-oxidative therapy for ameliorating cardiac injuries of critically ill COVID-19-infected patients	62
Explainable artificial intelligence to detect atrial fibrillation using electrocardiogram	59
Antithrombotic therapy in patients with COVID-19? -Rationale and Evidence-	55
Fulminant myocarditis and systemic hyperinflammation temporally associated with BNT162b2 mRNA COVID-19 vaccination in two patients	54
Filamin C variants are associated with a distinctive clinical and immunohistochemical arrhythmogenic cardiomyopathy phenotype	53
Acute pulmonary embolism in COVID-19 disease: Preliminary report on seven patients	50
Hepatocellular carcinoma and the Fontan circulation: Clinical presentation and outcomes	46
Arrhythmic profile and 24-hour QT interval variability in COVID-19 patients treated with hydroxychloroquine and azithromycin	46
Strategies of left ventricular unloading during VA-ECMO support: a network meta-analysis	45
Early detection of ST-segment elevated myocardial infarction by artificial intelligence with 12-lead electrocardiogram	44
A prospective study on the consequences of SARS-CoV-2 infection on the heart of young adult competitive athletes: Implications for a safe return-to-play	44
Short term outcomes of Impella in cardiogenic shock: A review and meta-analysis of observational studies	42
Impact of COVID-19 lockdown on lifestyle adherence in stay-at-home patients with chronic coronary syndromes: Towards a time bomb	40
MiR-135b protects cardiomyocytes from infarction through restraining the NLRP3/caspase-1/IL-1β pathway	39
Cost of inpatient heart failure care and 30-day readmissions in the United States	39
Detection of hypertrophic cardiomyopathy by an artificial intelligence electrocardiogram in children and adolescents	39
Current trends in mitral valve surgery: A multicenter national comparison between full-sternotomy and minimally-invasive approach	39
Diagnosis and Management of Rare Cardiomyopathies in Adult and Paediatric Patients. A Position Paper of the Italian Society of Cardiology (SIC) and Italian Society of Paediatric Cardiology (SICP)	39
Worldwide differences of hospitalization for ST-segment elevation myocardial infarction during COVID-19: A systematic review and meta-analysis	39

Left atrial strain as a pre-operative prognostic marker for patients with severe mitral regurgitation	39
Serial change of perivascular fat attenuation index after statin treatment: Insights from a coronary CT angiography follow-up study	39
Cardiotoxicity of the BCR-ABL1 tyrosine kinase inhibitors: Emphasis on ponatinib	39
LncRNA ZFAS1 confers inflammatory responses and reduces cholesterol efflux in atherosclerosis through regulating miR-654-3p-ADAM10/RAB22A axis	39
The effect of low-volume high-intensity interval training on cardiovascular health outcomes in type 2 diabetes: A randomised controlled trial	39
Native T1 and T2 provide distinctive signatures in hypertrophic cardiac conditions – Comparison of uremic, hypertensive and hypertrophic cardiomyopathy	39
Circulating interleukins in relation to coronary artery disease, atrial fibrillation and ischemic stroke and its subtypes: A two-sample Mendelian randomization study	38
Pharmacological therapy for the prevention of cardiovascular events in patients with myocardial infarction with non-obstructed coronary arteries (MINOCA): Insights from a multicentre national registry	38
Gender differences in the prevalence of frailty in heart failure: A systematic review and meta-analysis	37
Prevalence and clinical implications of eligibility criteria for prolonged dual antithrombotic therapy in patients with PEGASUS and COMPASS phenotypes: Insights from the START-ANTIPLATELET registry	37
“Concealed cardiomyopathy” as a cause of previously unexplained sudden cardiac arrest	37
Improved ventilation in premature babies after transcatheter versus surgical closure of patent ductus arteriosus	36
Current challenges for hypertension management: From better hypertension diagnosis to improved patients' adherence and blood pressure control	36
An Utstein-based model score to predict survival to hospital admission: The UB-ROSC score	36
Temporal changes in the incidence of infective endocarditis in Denmark 1997–2017: A nationwide study	36
External validation of a deep learning electrocardiogram algorithm to detect ventricular dysfunction	36
Use of Lifetech™ Konar-MF, a device for both perimembranous and muscular ventricular septal defects: A multicentre study	35
Oral anticoagulation and clinical outcomes in COVID-19: An Italian multicenter experience	35
Mortality and years of life lost of cardiovascular diseases in China, 2005–2020: Empirical evidence from national mortality surveillance system	35
Heart failure, frailty, and pre-frailty: A systematic review and meta-analysis of observational studies	35
In-vivo evidence of systemic endothelial vascular dysfunction in COVID-19	35
Sedentary behaviour in cardiovascular disease patients: Risk group identification and the impact of cardiac rehabilitation	35
Cardiotoxic mechanisms of cancer immunotherapy – A systematic review	34
Reduction in all-cause mortality in COVID-19 patients on chronic oral anticoagulation: A population-based propensity score matched study	34
Pulmonary hypertension after shunt closure in patients with simple congenital heart defects	33
SARS-CoV-2 inflames the heart. The importance of awareness of myocardial injury in COVID-19 patients	33
Higher mortality in acute coronary syndrome patients without standard modifiable risk factors: Results from a global meta-analysis of 1,285,722 patients	32
Protection of the enhanced Nrf2 deacetylation and its downstream transcriptional activity by SIRT1 in myocardial ischemia/reperfusion injury	32
Real-world effectiveness and safety of sacubitril/valsartan in heart failure: A systematic review	32
Dobutamine stress cardiac MRI is safe and feasible in pediatric patients with anomalous aortic origin of a coronary artery (AAOCA)	32
Acute myocardial infarction-cardiogenic shock in patients with prior coronary artery bypass grafting: A 16-year national cohort analysis of temporal trends, management and outcomes	32
Symptoms of anxiety and depression and risk of atrial fibrillation—The HUNT study	31
Why are women better protected from COVID-19: Clues for men? Sex and COVID-19	31
Long-term Follow-Up of Patients with Heart Failure and Reduced Ejection Fraction Receiving Autonomic Regulation Therapy in the ANTHEM-HF Pilot Study	30
Smartwatch Electrocardiogram and Artificial Intelligence for Assessing Cardiac-Rhythm Safety of Drug Therapy in the COVID-19 Pandemic. The QT-logs study	30
Cost-utility analysis of add-on dapagliflozin treatment in heart failure with reduced ejection fraction	30
Vasomotor dysfunction in patients with angina and nonobstructive coronary artery disease is dominated by vasospasm	30
Comorbidities and cause-specific outcomes in heart failure across the ejection fraction spectrum: A blueprint for clinical trial design	30
Myocardial injury and risk factors for mortality in patients with COVID-19 pneumonia	29
Intravascular ultrasound-guided versus coronary angiography-guided percutaneous coronary intervention in patients with acute myocardial infarction: A systematic review and meta-analysis	29
Rare variants in MTHFR predispose to occurrence and recurrence of pulmonary embolism	29
A systematic review of microRNAs in patients with hypertrophic cardiomyopathy	28
Cardiac involvement in consecutive unselected hospitalized COVID-19 population: In-hospital evaluation and one-year follow-up	28
CA125 outperforms NT-proBNP in acute heart failure with severe tricuspid regurgitation	28
Mechanical circulatory support for Takotsubo syndrome: a systematic review and meta-analysis	28
A morphology based deep learning model for atrial fibrillation detection using single cycle electrocardiographic samples	28
A plasma lipid signature predicts incident coronary artery disease	27
Research advances on circulating long noncoding RNAs as biomarkers of cardiovascular diseases	27
Commentary: What is the relationship between Covid-19 and cardiovascular disease?	27
Coronary anomalies in tetralogy of Fallot – A meta-analysis	27

The CNIC-Polypill reduces recurrent major cardiovascular events in real-life secondary prevention patients in Spain: The NEPTUNO study	27
Long-term intermittent versus short continuous heart rhythm monitoring for the detection of atrial fibrillation recurrences after catheter ablation	27
Identification of a novel presumed cardiac sarcoidosis category for patients at high risk of disease	26
Impact of sex on outcomes after cardiac surgery: A systematic review and meta-analysis	26
Atrial fibrillation in dilated cardiomyopathy: Outcome prediction from an observational registry	26
Left ventricular systolic dysfunction identification using artificial intelligence-augmented electrocardiogram in cardiac intensive care unit patients	26
Cardiovascular disease burden in adult patients with cancer: An 11-year nationwide population-based cohort study	26
MicroRNA-3614 regulates inflammatory response via targeting TRAF6-mediated MAPKs and NF-κB signaling in the epicardial adipose tissue with coronary artery disease	25
Increased risk of acute myocardial infarction after COVID-19 recovery: A systematic review and meta-analysis	25
Deep learning-based intravascular ultrasound segmentation for the assessment of coronary artery disease	25
COVID-19 and cardiovascular injury: A role for oxidative stress and antioxidant treatment?	25
LncRNA HCP5 in hBMSC-derived exosomes alleviates myocardial ischemia reperfusion injury by sponging miR-497 to activate IGF1/PI3K/AKT pathway	25
Enhanced detection of cardiac arrhythmias utilizing 14-day continuous ECG patch monitoring	25
Possible mechanism of late lumen enlargement after treatment for de novo coronary lesions with drug-coated balloon	24
Clinical features and complications of Loeys-Dietz syndrome: A systematic review	24
Standard and emerging CMR methods for mitral regurgitation quantification	24
Non-cardiology vs. cardiology care of patients with heart failure and reduced ejection fraction is associated with lower use of guideline-based care and higher mortality: Observations from The Swedish	24
Management perspectives from the 2019 Wuhan international workshop on fulminant myocarditis	24
Supra-annular sizing of transcatheter aortic valve prostheses in raphe-type bicuspid aortic valve disease: the LIRA method	24
Psychological and clinical characteristics of patients with spontaneous coronary artery dissection: A case-control study	23
Characteristics, prognosis and treatment response in distinct phenogroups of heart failure with preserved ejection fraction	23
Impact of COAPT trial exclusion criteria in real-world patients undergoing transcatheter mitral valve repair	23
Comparison of the self-expanding Evolut-PRO transcatheter aortic valve to its predecessor Evolut-R in the real world multicenter ATLAS registry	23
Value of circulating miRNA-1 detected within 3 h after the onset of acute chest pain in the diagnosis and prognosis of acute myocardial infarction	23
Outcome of arterial switch operation for transposition of the great arteries. A 35-year follow-up study	23
Automated extraction of left atrial volumes from two-dimensional computer tomography images using a deep learning technique	23
Association between long-term prescription of metformin and the progression of heart failure with preserved ejection fraction in patients with type 2 diabetes mellitus and hypertension	22
Iron deficiency for prognosis in acute coronary syndrome – A systematic review and meta-analysis	22
Natural history of severe tricuspid regurgitation: Outcomes after transcatheter tricuspid valve intervention compared to medical therapy	22
Second-generation cryoballoon-based pulmonary vein isolation: Lessons from a five-year follow-up	22
Current lipid lowering treatment and attainment of LDL targets recommended by ESC/EAS guidelines in very high-risk patients with established atherosclerotic cardiovascular disease: Insights from the S	22
Impact of COVID-19 pandemic and infection on in hospital survival for patients presenting with acute coronary syndromes: A multicenter registry	22
Comparison of cardiac function between left bundle branch pacing and right ventricular outflow tract septal pacing in the short-term: A registered controlled clinical trial	22
Quality assurance of quantitative cardiac T1-mapping in multicenter clinical trials – A T1 phantom program from the hypertrophic cardiomyopathy registry (HCMR) study	21
Standardization of T1-mapping in cardiovascular magnetic resonance using clustered structuring for benchmarking normal ranges	21
Hydroxychloroquine for colchicine-resistant glucocorticoid-dependent idiopathic recurrent pericarditis: A pilot observational prospective study	21
Risk prediction models for heart failure admissions in adults with congenital heart disease	21
Deep learning-based computer-aided heart sound analysis in children with left-to-right shunt congenital heart disease	21
C-reactive protein velocity predicts microvascular pathology after acute ST-elevation myocardial infarction	21
Machine learning-aided risk stratification system for the prediction of coronary artery disease	21
Cardiac microcalcifications in transthyretin (ATTR) amyloidosis	21
Myocardial ischemia: From disease to syndrome	21
Changes in the perceived epidemiology of amyloidosis: 20 year-experience from a Tertiary Referral Centre in Tuscany	21
Interatrial block and cognitive impairment in the BAYES prospective registry	21
Prognostic role of left ventricular apical aneurysm in hypertrophic cardiomyopathy: A systematic review and meta-analysis	21
Five-year mortality and readmission rates in patients with heart failure in India: Results from the Trivandrum heart failure registry	20
Left Atrial Strain changes in patients with breast cancer during anthracycline therapy	20
3-Dimensional personalized planning for transcatheter pulmonary valve implantation in a dysfunctional right ventricular outflow tract	20
Effect of exercise-based cardiac rehabilitation on clinical outcomes in patients with myocardial infarction in the absence of obstructive coronary artery disease (MINOCA)	20
The role of anti-hypertensive treatment, comorbidities and early introduction of LMWH in the setting of COVID-19: A retrospective, observational study in Northern Italy	20
Fontan-associated nephropathy: Predictors and outcomes	20
Evaluation of twelve formulas for LDL-C estimation in a large, blinded, random Italian population.	20
Cardiac microvascular functions improved by MSC-derived exosomes attenuate cardiac fibrosis after ischemia–reperfusion via PDGFR-β modulation	20
Prognostic significance of previous myocardial infarction and previous revascularization in patients undergoing SPECT MPI	20
Validity of epicardial fat volume as biomarker of coronary artery disease in symptomatic individuals: Results from the ALTER-BIO registry	20
Interpretation of elevated high-sensitivity cardiac troponin I in elite soccer players previously infected by severe acute respiratory syndrome coronavirus 2	20
Experimental abdominal aortic aneurysm growth is inhibited by blocking the JAK2/STAT3 pathway	20
Noninvasive biomarker-based risk stratification for development of new onset atrial fibrillation after coronary artery bypass surgery	19
Infective endocarditis in patients after percutaneous pulmonary valve implantation with the stent-mounted bovine jugular vein valve: Clinical experience and evaluation of the modified Duke criteria.	19
Serial changes in longitudinal strain are associated with outcome in children with hypoplastic left heart syndrome	19
22q11.2 deletion syndrome is associated with increased mortality in adults with tetralogy of Fallot and pulmonary atresia with ventricular septal defect	19
Cardiovascular magnetic resonance: What clinicians should know about safety and contraindications	19
Cardiogenic shock related cardiovascular disease mortality trends in US population: Heart failure vs. acute myocardial infarction as contributing causes	19
PINK1/Parkin-mediated mitophagy in cardiovascular disease: From pathogenesis to novel therapy	19
Hydroxychloroquine reduces interleukin-6 levels after myocardial infarction: The randomized, double-blind, placebo-controlled OXI pilot trial	19
Risk and predictors of sudden death in cardiac sarcoidosis: A systematic review and meta-analysis	19
METTL14 mediated m6A modification to LncRNA ZFAS1/ RAB22A: A novel therapeutic target for atherosclerosis	19
Heart failure in adults with congenital heart disease	19
Using machine learning to predict atrial fibrillation diagnosed after ischemic stroke	19
LDL cholesterol target achievement in heterozygous familial hypercholesterolemia patients according to 2019 ESC/EAS lipid guidelines: Implications for newer lipid-lowering treatments	19
Ischemia with no obstructive coronary artery disease (INOCA): A patient self-report quality of life survey from INOCA international	19
Timing of impella placement in PCI for acute myocardial infarction complicated by cardiogenic shock: An updated meta-analysis	19
Femoral transcatheter valve-in-valve implantation as alternative strategy for failed aortic bioprostheses: A single-centre experience with long-term follow-up	19
The role of balloon pulmonary angioplasty and pulmonary endarterectomy: Is chronic thromboembolic pulmonary hypertension still a life-threatening disease?	18
Real-world experience with implantable loop recorder monitoring to detect subclinical atrial fibrillation in patients with cryptogenic stroke: The value of p wave dispersion in predicting arrhythmia o	18
Cardiac resynchronization therapy for the failing systemic right ventricle: A systematic review	18
Efficacy and safety of balloon pulmonary angioplasty for residual pulmonary hypertension after pulmonary endarterectomy	18
Mechanical circulatory support for life-threatening arrhythmia: A systematic review	18
Functional heart recovery in an adult mammal, the spiny mouse	18
Coronary and aortic calcification are associated with cardiovascular events on immune checkpoint inhibitor therapy	18

Empagliflozin increases plasma levels of campesterol, a marker of cholesterol absorption, in patients with type 2 diabetes: Association with a slight increase in high-density lipoprotein cholesterol	18
LncRNA CDKN2B-AS1 hinders the proliferation and facilitates apoptosis of ox-LDL-induced vascular smooth muscle cells via the ceRNA network of CDKN2B-AS1/miR-126-5p/PTPN7	18
The anatomic substrate of mitral annular contraction	18
The effects of combination canagliflozin and glucagon-like peptide-1 receptor agonist therapy on intermediate markers of cardiovascular risk in the CANVAS program	18
Procedural and clinical outcomes of type 0 versus type 1 bicuspid aortic valve stenosis undergoing trans-catheter valve replacement with new generation devices: Insight from the BEAT international col	18
Transcatheter edge-to-edge mitral valve repair in atrial functional mitral regurgitation: insights from the multi-center MITRA-TUNE registry	18
Device deformation and left pulmonary artery obstruction after transcatheter patent ductus arteriosus closure in preterm infants	18
Polymorphisms in the IL-6 and TNF-α gene are associated with an increased risk of abdominal aortic aneurysm	18
Prediction of 1-year mortality after heart transplantation using machine learning approaches: A single-center study from China	18
The association between late-phase early recurrence within the blanking period after atrial fibrillation catheter ablation and long-term recurrence: Insights from a large-scale multicenter study	18
Clinical and echocardiographic outcomes of transcatheter mitral valve repair in atrial functional mitral regurgitation	18
Machine learning approach in diagnosing Takotsubo cardiomyopathy: The role of the combined evaluation of atrial and ventricular strain, and parametric mapping	18
Prevalence and characteristics of myocardial injury during COVID-19 pandemic: A new role for high-sensitive troponin	18
Systolic dysfunction of the subpulmonary left ventricle is associated with the severity of heart failure in patients with a systemic right ventricle	18
Long-term variations of FFR and iFR after transcatheter aortic valve implantation	18
Effectiveness and safety of infliximab in cardiac Sarcoidosis	18
The tricuspid annular plane systolic excursion to systolic pulmonary artery pressure index: Association with all-cause mortality in patients with moderate or severe tricuspid regurgitation	18
Validation of the ABCD-GENE score to identify high platelet reactivity in east Asian patients undergoing percutaneous coronary intervention	18
Feasibility of late gadolinium enhancement (LGE) in ischemic cardiomyopathy using 2D-multisegment LGE combined with artificial intelligence reconstruction deep learning noise reduction algorithm	18
Post-prandial effects of high-polyphenolic extra virgin olive oil on endothelial function in adults at risk for type 2 diabetes: A randomized controlled crossover trial	18
Structural brain abnormalities in adults with congenital heart disease: Prevalence and association with estimated intelligence quotient	17
A new approach to the clinical subclassification of heart failure with preserved ejection fraction	17
Pre-admission acetylsalicylic acid therapy and impact on in-hospital outcome in COVID-19 patients: The ASA-CARE study	17
LncRNA KCNQ1OT1 as a miR-26a-5p sponge regulates ATG12-mediated cardiomyocyte autophagy and aggravates myocardial infarction	17
Effect of febuxostat on clinical outcomes in patients with hyperuricemia and cardiovascular disease	17
Impact of predictive value of Fibrosis-4 index in patients hospitalized for acute heart failure	17
Stress activated signalling impaired protein quality control pathways in human hypertrophic cardiomyopathy	17
Acute electrical, autonomic and structural effects of binge drinking: Insights into the ‘holiday heart syndrome’	17
Sacubitril/valsartan for the management of heart failure: A perspective viewpoint on current evidence	17
Revascularization decisions in patients with chronic coronary syndromes: Results of the second International Survey on Interventional Strategy (ISIS-2)	17
Prevalence of transthyretin amyloid cardiomyopathy in male patients who underwent bilateral carpal tunnel surgery: The ACTUAL study	17
Dexmedetomidine alleviates myocardial ischemia/reperfusion-induced injury and Ca2+ overload via the microRNA-346-3p/CaMKIId axis	17
Translating results from the cardiovascular outcomes trials with glucagon-like peptide-1 receptor agonists into clinical practice: Recommendations from a Eastern and Southern Europe diabetes expert gr	17
Non-invasive assessment of endothelial function in patients with spontaneous coronary artery dissection: A case-control study	17
Causal effect of sex hormone-binding globulin and testosterone on coronary heart disease: A multivariable and network Mendelian randomization analysis	17
Cardiovascular manifestations in hospitalized patients with hemochromatosis in the United States	17
Cognitive impairment in patients with atrial fibrillation: Implications for outcome in a cohort study	17
Spectrum of cardiac involvement in patients with dengue fever	17
Cardiovascular disease-specific mortality in 270,618 patients with non-small cell lung cancer	17
Duchenne and Becker muscular dystrophy carriers: Evidence of cardiomyopathy by exercise and cardiac MRI testing	17
Disproportionately low BNP levels in patients of acute heart failure with preserved vs. reduced ejection fraction	17
Myocarditis after RNA-based vaccines for coronavirus.	17
Exacerbation of autoimmune myocarditis by an immune checkpoint inhibitor is dependent on its time of administration in mice	17
Assessing QT interval in COVID-19 patients:safety of hydroxychloroquine-azithromycin combination regimen	17
Creating the BELgian COngenital heart disease database combining administrative and clinical data (BELCODAC): Rationale, design and methodology	17
Health-related quality of life and incident cardiovascular disease events in community-dwelling older people: A prospective cohort study	17
Prognostic nutritional index and the risk of mortality in patients with hypertrophic cardiomyopathy	16
Left atrial appendage occlusion in atrial fibrillation patients with previous intracranial bleeding: A national multicenter study	16
Treatment prescription, adherence, and persistence after the first hospitalization for heart failure: A population-based retrospective study on 100785 patients	16
Aerobic exercise and inspiratory muscle training increase functional capacity in patients with univentricular physiology after Fontan operation: A randomized controlled trial	16
Accuracy of a novel stress echocardiography pattern for myocardial bridging in patients with angina and no obstructive coronary artery disease – A retrospective and prospective cohort study	16
Prevalence, causes and predictors of cardiovascular hospitalization in patients with hypertrophic cardiomyopathy	16
A survey of retractions in the cardiovascular literature	16
Comparative effectiveness of SGLT2i versus GLP1-RA on cardiovascular outcomes in routine clinical practice	16
Acute-phase initiation of cardiac rehabilitation and clinical outcomes in hospitalized patients for acute heart failure	16
Syncope in hypertrophic cardiomyopathy (part I): An updated systematic review and meta-analysis	16
The combined effects of cardiac geometry, microcirculation, and tissue characteristics on cardiac systolic and diastolic function in subclinical diabetes mellitus-related cardiomyopathy	16
Spontaneous reported cardiotoxicity induced by lopinavir/ritonavir in COVID-19. An alleged past-resolved problem	16
Impact of cancer diagnosis on causes and outcomes of 5.9 million US patients with cardiovascular admissions	16
Clinical features and prognosis of patients with spontaneous coronary artery dissection	16
Post-PCI outcomes predicted by pre-intervention simulation of residual quantitative flow ratio using augmented reality	16
Filling the gap between Guidelines and Real World in the cardiovascular approach to the diabetic patients: the need for a call to action	16
Acute myocardial infarction in a high-risk cancer population: Outcomes following conservative versus invasive management	16
The role of a comprehensive two-step diagnostic evaluation to unravel the pathophysiology of MINOCA: A review	16
Performance of the H2FPEF and the HFA-PEFF scores for the diagnosis of heart failure with preserved ejection fraction in Japanese patients: A report from the Japanese multicenter registry	16
Comparison of fluoroscopy and transesophageal echocardiogram for intra-procedure device surveillance assessment during implantation of Watchman	16
Prognostic role of global longitudinal strain by feature tracking in patients with hypertrophic cardiomyopathy: The STRAIN-HCM study	16
Clinical relevance and prognostic implications of contrast quantitative flow ratio in patients with coronary artery disease	16
A critical analysis of 57 cases of Hughes-Stovin syndrome (HSS). A report by the HSS International Study Group (HSSISG)	16
Human coronary inflammation by computed tomography: Relationship with coronary microvascular dysfunction	16
Clinical impact and room for improvement of intensity and adherence to lipid lowering therapy: Five years of clinical follow-up from 164,565 post-myocardial infarction patients	16
Prediction of new-onset atrial fibrillation for general population in Asia: A comparison of C2HEST and HATCH scores	16
Long-term outcomes of early-onset myocardial infarction with non-obstructive coronary artery disease (MINOCA)	16
Infarct size following loading with Ticagrelor/Prasugrel versus Clopidogrel in ST-segment elevation myocardial infarction	16
Cardiovascular health metrics and all-cause mortality and mortality from major non-communicable chronic diseases among Chinese adult population	15
Point of care, bone marrow mononuclear cell therapy in ischemic heart failure patients personalized for cell potency: 12-month feasibility results from CardiAMP heart failure roll-in cohort	15
Hyperglycemia-induced endothelial dysfunction is alleviated by thioredoxin mimetic peptides through the restoration of VEGFR-2-induced responses and improved cell survival	15
Catheterization laboratory activity before and during COVID-19 spread: A comparative analysis in Piedmont, Italy, by the Italian Society of Interventional Cardiology (GISE)	15
DNA methylation of hypertension-related genes and effect of riboflavin supplementation in adults stratified by genotype for the MTHFR C677T polymorphism	15
Transcervical approach versus transfemoral approach for transcatheter aortic valve replacement	15
Long-term outcome of prosthesis-patient mismatch after transcatheter aortic valve replacement	15
Impact of myocardial injury and inflammation due to ablation on the short-term and mid-term outcomes: Cryoballoon versus laser balloon ablation	15
The globe on the spotlight: Coronavirus disease 2019 (Covid-19)	15
Echocardiography and cardiac magnetic resonance in children with repaired tetralogy of Fallot: New insights in cardiac mechanics and exercise capacity	15
Revascularization versus medical therapy for the treatment of stable coronary artery disease: A meta-analysis of contemporary randomized controlled trials	15
Blockade of the neurohormonal systems in heart failure with preserved ejection fraction: A contemporary meta-analysis	15
Cold ischemia >4 hours increases heart transplantation mortality. An analysis of the Spanish heart transplantation registry	15
Left atrial contractile strain predicts recurrence of atrial tachyarrhythmia after catheter ablation	15
National prevalence, trends and outcomes of takotsubo syndrome in hospitalizations with prior history of mediastinal/intrathoracic cancer and radiation therapy	15
The best way to transcatheter aortic valve implantation: From standard to new approaches	15
Direct oral anticoagulant use and outcomes in adult patients with Fontan circulation: A multicenter retrospective cohort study	15
Kinetics of procalcitonin, C-reactive protein and interleukin-6 in cardiogenic shock – Insights from the CardShock study	15
Myval versus alternative balloon- and self-expandable transcatheter heart valves: A central core lab analysis of conduction disturbances.	15
Associations between changes in serum uric acid and the risk of myocardial infarction	15
Long-term clinical outcomes in patients with a working diagnosis of myocardial infarction with non-obstructed coronary arteries (MINOCA) assessed by cardiovascular magnetic resonance imaging	14